TITLE

Therapeutic approaches to reflux disease, focusing on acid secretion

AUTHOR(S)
Kinoshita, Yoshikazu; Adachi, Kyoichi; Fujishiro, Hirofumi
PUB. DATE
March 2003
SOURCE
Journal of Gastroenterology;2003 Supplement 15, Vol. 38, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Gastroesophageal reflux disease (GERD) is caused by a combination of esophageal motor dysfunction accompanied by maintained gastric acid secretion. Noninvasive medical treatment of GERD is mainly provided by inhibiting gastric acid secretion, because this is easier than restoring esophageal motor function by administration of drugs. Proton pump inhibitors (PPIs) and histamine H, receptor antagonists (H2RAs) are two major acid-suppressing drugs used for the treatment of GERD. PPIs have better characteristics for the long-term treatment of GERD, because they have a long-lasting, strong effect of raising intragastric pH and have no tachyphylaxis/tolerance phenomena on repeated dosing. Some patients with Helicobacter pylori-negative high-grade GERD may show nocturnal decreases in pH during treatment with PPIs and resistance to treatment with PPI. For these patients, addition of H2RAs to PPIs can be useful for controlling GERD, at least for short-term treatment. For long-term control of such cases, further studies are necessary.
ACCESSION #
18317295

 

Related Articles

  • Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Rackoff, A.; Agrawal, A.; Hila, A.; Mainie, I.; Tutuian, R.; Castell, D. O. // Diseases of the Esophagus;Dec2005, Vol. 18 Issue 6, p370 

    While night-time symptoms of gastroesophageal reflux disease (GERD) are common, considerable controversy exists regarding the use of histamine-2 receptor antagonists (H2Ras) for night-time reflux control. Some studies have suggested possible tolerance to H2RA while others have suggested that...

  • Intravenous Esomeprazole: A Viewpoint by Peter Bytzer. Bytzer, Peter // Drugs;2004, Vol. 64 Issue 8, p883 

    The intravenous proton pump inhibitor esomeprazole is effective in treating gastroesophageal reflux disease by controlling gastric acid and increasing intragastric pH levels. It has a slower metabolic clearance and longer intragastric pH control. Intravenous esomeprazole is well-tolerated. Its...

  • Acid Reflux Detection and Symptom-Reflux Association Using 4-Day Wireless pH Recording Combining 48-Hour Periods Off and On PPI Therapy. Garrean, Carol P.; Qing Zhang; Gonsalves, Nirmala; Hirano, Ikuo // American Journal of Gastroenterology;Jul2008, Vol. 103 Issue 7, p1631 

    OBJECTIVES: Studies have shown that extended pH recording improves the sensitivity of esophageal pH monitoring. Controversy exists as to whether pH studies are optimally done off or on proton pump inhibitor (PPI) therapy. The aim of this study was to incorporate periods both off and on PPI...

  • Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Fontes, L. H. S.; Herbella, F. A. M.; Rodriguez, T. N.; Trivino, T.; Farah, J. F. M. // Diseases of the Esophagus;Jul2013, Vol. 26 Issue 5, p470 

    SUMMARY The progression of certain primary esophageal motor disorders to achalasia has been documented; however, the true incidence of this decay is still elusive. This study aims to evaluate: (i) the incidence of the progression of diffuse esophageal spasm to achalasia, and (ii) predictive...

  • Esophageal Acid Exposure Decreases Intraluminal Baseline Impedance Levels. Kessing, Boudewijn F; Bredenoord, Albert J; Weijenborg, Pim W; Hemmink, Gerrit J M; Loots, Clara M; Smout, A J P M // American Journal of Gastroenterology;Dec2011, Vol. 106 Issue 12, p2093 

    OBJECTIVES:Intraluminal baseline impedance levels are determined by the conductivity of the esophageal wall and can be decreased in gastroesophageal reflux disease (GERD) patients. The aim of this study was to investigate the baseline impedance in GERD patients, on and off proton pump inhibitor...

  • Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ‘On’ or ‘Off’ Proton Pump Inhibitor? Hemmink, Gerrit J. M.; Bredenoord, Albert J.; Weusten, Bas L. A. M.; Monkelbaan, Jan F.; Timmer, Robin; Smout, André J. P. M. // American Journal of Gastroenterology;Oct2008, Vol. 103 Issue 10, p2446 

    BACKGROUND: In patients with proton pump inhibitor (PPI)-resistant symptoms, ambulatory 24-h pH-impedance monitoring can be used to assess whether a relationship exists between symptoms and reflux episodes. Until now, it is unclear whether combined pH-impedance monitoring in these patients...

  • Esophageal pH-Impedance Monitoring and Symptom Analysis in GERD: A Study in Patients off and on Therapy. Zerbib, Frank; Roman, Sabine; Ropert, Alain; des Varannes, Stanislas Bruley; Pouderoux, Philippe; Chaput, Ulriikka; Mion, François; Vérin, Eric; Galmiche, Jean-Paul; Sifrim, Daniel // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p1956 

    INTRODUCTION: Combined esophageal pH-impedance monitoring allows detection of nearly all gastroesophageal reflux episodes, acid as well as nonacid. However, the role of nonacid reflux in the pathogenesis of symptoms is poorly known. The aim of this study was to evaluate the diagnostic yield of...

  • Addition of Esophageal Impedance Monitoring to pH Monitoring Increases the Yield of Symptom Association Analysis in Patients off PPI Therapy. Bredenoord, Albert J.; Weusten, Bas L. A. M.; Timmer, Robin; Conchillo, José M.; Smout, André J. P. M. // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p453 

    BACKGROUND: The additional yield of esophageal impedance monitoring in identification of reflux as the cause of reflux symptoms is unknown. OBJECTIVES: To compare the yield of symptom–reflux association analysis of combined esophageal pH-impedance data with the yield of analysis of pH...

  • Globus sensation and gastroesophageal reflux. Chevalier, Julia M.; Brossard, Edgar; Monnier, Philippe // European Archives of Oto-Rhino-Laryngology;May2003, Vol. 260 Issue 5, p273 

    Recent studies suggest that gastroesophageal reflux disease (GERD) may be a major cause of globus sensation. However, the incidence and severity of GERD in patients with globus sensation without reflux symptoms are unknown. In order to establish the relationship between globus sensation in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics